Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial - Concepedia

Concepedia

Publication | Open Access

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

DOI Full Paper Access

166

Citations

23

References

2020

Year

Till Koch, Christine Dahlke, Anahita Fathi, Alexandra Kupke, Verena Krähling, Nisreen M.A. Okba, Sandro Halwe, Cornelius Rohde, Markus Eickmann, Asisa Volz,

The Lancet Infectious Diseases

References

	Year	Citations

Page 1